Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-05-23

Clinical Trial Update: Administration of Prazosin to Prevent PTSD in Adult Women After Sexual Assault [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the use of prazosin to prevent posttraumatic stress disorder in adult women after sexual assault was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin (prazosin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Posttraumatic Stress Disorder | Phase 4 | Status: WITHDRAWN